Core Viewpoint - Align Technology, Inc. (ALGN) is expected to report its second-quarter 2025 results on July 30, with adjusted earnings per share (EPS) anticipated at $2.57, reflecting a 6.6% increase year-over-year, and revenues projected at $1.06 billion, indicating a 3.2% rise from the previous year [1][2][7]. Group 1: Earnings and Revenue Estimates - The Zacks Consensus Estimate for revenues is set at $1.06 billion, suggesting a 3.2% increase from the year-ago figure [2]. - The Zacks Consensus Estimate for earnings is pinned at $2.57 per share, implying a 6.6% rise from the year-ago recorded actuals [2]. - Estimates for second-quarter earnings have remained unchanged at $2.57 per share over the past 30 days [3]. Group 2: Business Performance Factors - The Clear Aligner business is expected to show strength in volumes for both teens and adult patients, particularly in the APAC and EMEA regions, driven by orthodontic and GP dentist channels [4]. - In the first quarter, Clear Aligner volume from DSO customers increased year-over-year, with significant growth in the U.S. DSO business, benefiting from partnerships with SmileDoctors and Heartland Dental [5]. - The approval of the Invisalign Palatal Expander System in China and the introduction of the Invisalign System with mandibular advancement are anticipated to contribute positively to second-quarter revenues [6]. Group 3: Systems & Services Business - The Systems & Services business is projected to experience growth due to increased scanner volumes and non-system revenues from iTero Lumina wand upgrades [7]. - The launch of next-generation iTero Lumina solutions and Align X-ray Insights is expected to have a positive impact on the company's second-quarter top line [9]. - The positive customer response to the iTero Lumina Scanner with ortho workflow is likely to have boosted revenues [8].